Jan Willem Vrijbloed
Technik-/Wissenschafts-/F&E-Leiter bei Neurotune AG
Profil
Jan Willem Vrijbloed is currently working as the Director-Preclinical & Clinical Development at Neurotune AG.
Previously, he worked as a Principal at the University of Zurich and as the Head-Development at Spexis Ltd.
He holds a doctorate degree from the University of Groningen.
Aktive Positionen von Jan Willem Vrijbloed
| Unternehmen | Position | Beginn |
|---|---|---|
Neurotune AG
 Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Technik-/Wissenschafts-/F&E-Leiter | 04.11.2009 |
Ehemalige bekannte Positionen von Jan Willem Vrijbloed
| Unternehmen | Position | Ende |
|---|---|---|
| SPEXIS AG | Corporate Officer/Principal | - |
| University of Zurich | Corporate Officer/Principal | - |
Ausbildung von Jan Willem Vrijbloed
| University of Groningen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SPEXIS AG | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Neurotune AG
Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Health Technology |
